Repeat dose toxicity study

Ended Awarded Last action

Contract number
0002
Awardee
Awarding agency
Obligated
$413,698

Award facts

Opportunity
  • W81XWH13R0038 Solicitation number
Contract value 100% obligated
$413,697.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21703, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $413,698

About this award

This is a $413,697.84 Cost Plus Fixed Fee delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Leidos, Inc. The contract is under the Medical Product Research and Development indefinite delivery vehicle (IDV) and is for a Repeat Dose Toxicity Study. Leidos has subcontracted a portion of the work to SNBL U.S.A., LTD. The contract does not have a set-aside designation. This award supports MEDCOM's medical research programs, which encompass efforts related to traumatic brain injury, psychological health, cancer, and rare diseases.

Quick answers

Who was awarded contract 0002?

0002 was awarded to Leidos, Inc. by Medical Command (Department of the Army) on September 23, 2016.

How much is contract 0002 worth?

The government has obligated $413,698 on 0002.

Is contract 0002 an order under another contract?

Yes. 0002 is a delivery order under W81XWH15D0039, an indefinite delivery contract, on Medical Product Research and Development.

Was contract 0002 competed?

The extent of competition for 0002 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award